467 related articles for article (PubMed ID: 15356030)
1. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
[TBL] [Abstract][Full Text] [Related]
2. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
[TBL] [Abstract][Full Text] [Related]
3. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
Kappy M; Stuart T; Perelman A; Clemons R
J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
[TBL] [Abstract][Full Text] [Related]
4. Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection.
Demirbilek H; Alikasifoglu A; Gonc NE; Ozon A; Kandemir N
Clin Endocrinol (Oxf); 2012 Jan; 76(1):126-30. PubMed ID: 21790701
[TBL] [Abstract][Full Text] [Related]
5. Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
Vurallı D; Alikaşifoğlu A; İyigün İ; Canoruç D; Ozon A; Gönç N; Kandemir N
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):37-44. PubMed ID: 31347350
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty.
Lee PA; Klein K; Mauras N; Neely EK; Bloch CA; Larsen L; Mattia-Goldberg C; Chwalisz K
J Clin Endocrinol Metab; 2012 May; 97(5):1572-80. PubMed ID: 22344198
[TBL] [Abstract][Full Text] [Related]
7. Treatment of central precocious puberty: comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy.
Witchel SF; Baens-Bailon RG; Lee PA
J Clin Endocrinol Metab; 1996 Apr; 81(4):1353-6. PubMed ID: 8636332
[TBL] [Abstract][Full Text] [Related]
8. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
Garibaldi LR; Aceto T; Weber C; Pang S
J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
[TBL] [Abstract][Full Text] [Related]
9. Utility of single luteinizing hormone determination 3 h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty.
Acharya SV; Gopal RA; George J; Bandgar TR; Menon PS; Shah NS
Pituitary; 2009; 12(4):335-8. PubMed ID: 19396631
[TBL] [Abstract][Full Text] [Related]
10. Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty.
Cook JS; Doty KL; Conn PM; Hansen JR
J Clin Endocrinol Metab; 1992 May; 74(5):1206-9. PubMed ID: 1569169
[TBL] [Abstract][Full Text] [Related]
11. Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg).
Carel JC; Lahlou N; Jaramillo O; Montauban V; Teinturier C; Colle M; Lucas C; Chaussain JL
J Clin Endocrinol Metab; 2002 Sep; 87(9):4111-6. PubMed ID: 12213857
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment?
Kunz GJ; Sherman TI; Klein KO
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1189-98. PubMed ID: 18183790
[TBL] [Abstract][Full Text] [Related]
13. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
[TBL] [Abstract][Full Text] [Related]
14. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
[TBL] [Abstract][Full Text] [Related]
15. Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty.
Badaru A; Wilson DM; Bachrach LK; Fechner P; Gandrud LM; Durham E; Wintergerst K; Chi C; Klein KO; Neely EK
J Clin Endocrinol Metab; 2006 May; 91(5):1862-7. PubMed ID: 16449344
[TBL] [Abstract][Full Text] [Related]
16. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
17. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test.
Ibáñez L; Potau N; Zampolli M; Virdis R; Gussinyé M; Carrascosa A; Saenger P; Vicens-Calvet E
J Clin Endocrinol Metab; 1994 Jan; 78(1):30-5. PubMed ID: 7507123
[TBL] [Abstract][Full Text] [Related]
18. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
Lee HS; Yoon JS; Roh JK; Hwang JS
Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
[TBL] [Abstract][Full Text] [Related]
19. Triptorelin depot stimulation test for central precocious puberty.
Strich D; Kvatinsky N; Hirsch HJ; Gillis D
J Pediatr Endocrinol Metab; 2013; 26(7-8):631-4. PubMed ID: 23425599
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty.
Neely EK; Wilson DM; Lee PA; Stene M; Hintz RL
J Pediatr; 1995 Jul; 127(1):47-52. PubMed ID: 7608810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
